Dr Véronique Walsh joins BMS
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibb has appointed Dr Véronique Walsh business unit director, neuroscience and immunoscience. She will lead the sales and marketing teams for the company's neuroscience and immunoscience portfolio, which includes Orencia (abatacept), Abilify (aripiprazole) and Perfalgan (paracetamol IV), as well as investigational products. Dr Walsh has 20 years' experience within the vaccines industry, most recently serving as deputy managing director in charge of market access, public affairs, communications, and strategic planning at Sanofi Pasteur MSD UK.